PR NewswireBEIJING, March 25, 2025
BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-p
BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ('iHuman' or the 'Company'), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.
With U.S. stock futures trading slightly higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
iHuman Inc. IH ...
iHuman press release (IH): Q3 GAAP EPADS of $0.07.
Revenue of $34.1M (-4.7% Y/Y).
Average total MAUs reached a record-high of 29.12 million, a year-over-year increase of 14.8%.
PR NewswireBEIJING, Dec. 26, 2024
BEIJING, Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-pow
BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ('iHuman' or the 'Company'), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”)...
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) — Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday,…
Key Takeaways: iHuman’s revenue and profit both declined in the first quarter as it accelerated a global expansion plan to diversify beyond its softening home market in China The company’s gross margin and total users both improved, but the omission of its latest paid user count suggests that key metric continued to decline
iHuman ADS press release (IH): Q3 Non-GAAP EPADS of $0.14.
Revenue of $35.8M, an increase of 4.0% Y/Y.
Average total MAUs reached a record-high of 25.36 million, a year-over-year increase of
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on...
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 8th and 9th, 2023
GlobeNewswire
November 01, 2023
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Wednesday, November 8 and Thursday,...
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.